A Chicken-and-Egg Predicament: Malignant Hypertension Versus HIV-Induced Thrombotic Microangiopathic Anemia Conundrum. [PDF]
Zamanian D +4 more
europepmc +1 more source
ABSTRACT The impacts of cardiometabolic risk factors (CMRFs) and the biomarkers on disease severity in metabolic dysfunction‐associated steatotic liver disease (MASLD) remain elusive. Accordingly, a multicenter study by recruiting MASLD patients from a nationwide registry database was conducted with a total of 2882 MASLD patients (54.1% males, mean age
Jee‐Fu Huang +14 more
wiley +1 more source
Successful treatment of severe renal failure caused by malignant hypertension using a combination of renin-angiotensin-aldosterone system inhibitors: a case report. [PDF]
Harada W +7 more
europepmc +1 more source
Determinants of Early Renal Function Recovery After TIPS in Patients With Portal Hypertension
ABSTRACT Renal dysfunction frequently occurs in patients with portal hypertension and is linked to unfavorable clinical outcomes. Transjugular intrahepatic portosystemic shunt (TIPS) has the potential to enhance renal perfusion through portal decompression; however, factors predicting early improvement in renal function remain insufficiently defined ...
Meng Jia +6 more
wiley +1 more source
Urinary complement factor D is increased in primary malignant hypertension: a single-center, cross-sectional study. [PDF]
Cheng Y, Qin W, Lin L, Gao Y, Li M.
europepmc +1 more source
Postoperative Hypocalcemia Following Total Thyroidectomy Versus Completion Thyroidectomy
Completion thyroidectomy performed with at least a three‐month interval demonstrates superior parathyroid preservation compared to primary total thyroidectomy, as evidenced by significantly higher postoperative parathyroid hormone levels (51.90 ± 30.26 pg/mL vs. 30.90 ± 17.10 pg/mL, p = 0.006).
Mehmet Turan Cicek +3 more
wiley +1 more source
What came first, atypical hemolytic uremic syndrome or malignant hypertension: a clinical dilemma. [PDF]
Sethi SK +6 more
europepmc +1 more source
Correction: Case presentation: a severe case of cobalamin c deficiency presenting with nephrotic syndrome, malignant hypertension and hemolytic anemia. [PDF]
Akar HT +5 more
europepmc +1 more source
Case presentation: a severe case of cobalamin c deficiency presenting with nephrotic syndrome, malignant hypertension and hemolytic anemia. [PDF]
Akar HT +5 more
europepmc +1 more source

